Sumitomo Mitsui Ds Asset Management Company, LTD Jazz Pharmaceuticals PLC Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

$9.15 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$122.0 - $145.31 $1,708 - $2,034	-14 Reduced 0.33%	4,267 $552,000
Q2 2023 Aug 04, 2023	SELL	$122.5 - $147.16 $1,715 - $2,060	-14 Reduced 0.33%	4,281 $530,000
Q4 2022 Jan 26, 2023	BUY	$129.72 - $159.85 $2,983 - $3,676	23 Added 0.54%	4,295 $0
Q3 2022 Oct 19, 2022	BUY	$126.59 - $161.18 $4,937 - $6,286	39 Added 0.92%	4,272 $569,000
Q2 2022 Jul 13, 2022	BUY	$141.59 - $168.66 $210,261 - $250,460	1,485 Added 54.04%	4,233 $660,000
Q1 2022 Apr 19, 2022	SELL	$129.64 - $160.7 $16,464 - $20,408	-127 Reduced 4.42%	2,748 $428,000
Q4 2021 Jan 20, 2022	BUY	$119.87 - $145.67 $1,798 - $2,185	15 Added 0.52%	2,875 $366,000
Q3 2021 Oct 15, 2021	SELL	$128.64 - $184.79 $3,087 - $4,434	-24 Reduced 0.83%	2,860 $372,000
Q2 2021 Jul 19, 2021	SELL	$160.2 - $186.42 $2,242 - $2,609	-14 Reduced 0.48%	2,884 $512,000
Q1 2021 May 07, 2021	BUY	$150.19 - $173.5 $3,754 - $4,337	25 Added 0.87%	2,898 $476,000
Q4 2020 Feb 02, 2021	SELL	$140.71 - $165.05 $3,517 - $4,126	-25 Reduced 0.86%	2,873 $474,000
Q1 2020 Apr 21, 2020	BUY	$87.74 - $152.74 $1,842 - $3,207	21 Added 0.73%	2,898 $289,000
Q4 2019 Jan 24, 2020	BUY	$117.65 - $153.73 $8,235 - $10,761	70 Added 2.49%	2,877 $429,000
Q2 2019 Aug 13, 2019	SELL	$125.55 - $144.48 $115,882 - $133,355	-923 Reduced 24.75%	2,807 $400,000
Q1 2018 Apr 25, 2018	SELL	$135.59 - $157.16 $59,524 - $68,993	-439 Reduced 10.53%	3,730 $563,000
Q4 2017 Jan 25, 2018	SELL	$131.06 - $150.39 $16,251 - $18,648	-124 Reduced 2.89%	4,169 $561,000
Q3 2017 Oct 27, 2017	BUY	$142.62 - $155.6 $612,267 - $667,990	4,293	4,293 $627,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Account